“Osteogenesis Imperfecta Patients Wish Orthopedic Surgeons Had Better Strategies to Help with…”—Results of a Patient and Parent-Oriented Survey
Open Access
Abstract
Osteogenesis Imperfecta (OI) is a rare genetic disorder in Type I collagen characterized by bone fractures, fragility, and deformity. Current treatments are focused on decreasing fracture rates, improving bone strength, and improving overall global function. Recent research has focused primarily on fracture fixation and outcomes of intramedullary rodding of long bones. While surgical techniques continue to evolve, recent trends in OI research are focusing on patient quality of life and patient-reported outcomes. We created a 12-question survey seeking information regarding aspects of orthopedic care that OI patients and families feel are the most pressing to improve. The survey was electronically administered, and 341 individuals participated. A total of 75% of respondents who answered the age question (254/335) were adults. Regarding surgical intervention for long bones, only 16% of respondents recall being told they could not have surgery because they were too young. Of the 16%, 37.8% were told that <5 years was too young, 13.4% <4 years was too young, and 48.8% <3 years of age was too young for surgical intervention for fractures or deformities. Nearly 22% of respondents were told that their bones were too small for intramedullary fixation. The patient and family responses help elucidate the topics requiring focus for the improvement of OI orthopedic care. Patient concerns and insights should drive the research questions we ask to advance the orthopedic care of OI patients.Keywords
This publication has 22 references indexed in Scilit:
- Olecranon Fractures in Pediatric Patients With Osteogenesis ImperfectaJournal of Pediatric Orthopaedics, 2019
- Osteogenesis Imperfecta: New Perspectives From Clinical and Translational ResearchJBMR Plus, 2019
- Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta communityOsteoporosis International, 2018
- Osteogenesis imperfectaNature Reviews Disease Primers, 2017
- Pharmacological and biological therapeutic strategies for osteogenesis imperfectaAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2016
- Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort StudyJournal of Bone and Mineral Research, 2016
- Analysis of skeletal dysplasias in the Utah populationAmerican Journal of Medical Genetics Part A, 2012
- New perspectives on osteogenesis imperfectaNature Reviews Endocrinology, 2011
- Fassier–Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: Functional outcomes at one yearJournal of Children's Orthopaedics, 2011
- The birth prevalence rates for the skeletal dysplasias.Journal of Medical Genetics, 1986